Skip to main content

OrbiMed Advisors LLC's Form 4 filing

PMV Pharmaceuticals, Inc. (PMVP) · filed Mar 31, 2022

Accession no.
0000947871-22-000429
Filed
Mar 31, 2022, 5:30 PM ET
Trade date
Mar 29-31, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market sales total $10.3M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 000105595110% Owner
OrbiMed Capital LLCCIK 000115752410% Owner
OrbiMed Capital GP V LLCCIK 000161537410% Owner
OrbiMed Genesis GP LLCCIK 000180874410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 29, 2022Common StockSSaleDisposed−365,000$21.52F1−$7,854,800109,500Indirect
Mar 30, 2022Common StockSSaleDisposed−75,000$22.39F2−$1,679,25034,500Indirect
Mar 31, 2022Common StockSSaleDisposed−34,500$21.17F3−$730,3650Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $21.52.

Referenced by the price of 1 transaction in Table I.

F2

These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $22.39.

Referenced by the price of 1 transaction in Table I.

F3

These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $21.17.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)